Cargando…
Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms
Tardive dyskinesia (TD) is a prevalent movement disorder that significantly impacts patients with schizophrenia (SCZ) due to extended exposure to antipsychotics (AP). Several genetic polymorphisms, including superoxide dismutase (SOD) and DRD3 9ser, have been suggested as explanations why some patie...
Autores principales: | Uludag, Kadir, Wang, Dong Mei, Zhang, Xiang Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635956/ https://www.ncbi.nlm.nih.gov/pubmed/36338339 http://dx.doi.org/10.1155/2022/5748924 |
Ejemplares similares
-
Relevance of animal models to human tardive dyskinesia
por: Blanchet, Pierre J, et al.
Publicado: (2012) -
Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011) -
METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983) -
Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz, Stacey K
Publicado: (2013) -
Recent Advances in the Pharmacology of Tardive Dyskinesia
por: Caroff, Stanley N.
Publicado: (2020)